Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy

Pharmacology

Volumn 72, Issue 3, 2004, Pages 190-195

  Patil, Chandrashekhar S ^a   Singh, Vijay Pal ^a   Singh, Sukhjeet ^b   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

^b Panacea Biotec Ltd   (India)

Author keywords

Diabetic neuropathy; Hyperalgesia or hyperesthesia; PDE 5 inhibitors

Indexed keywords

CARBENE; N(G) NITROARGININE METHYL ESTER; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HYPERALGESIA; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PATHOGENESIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPERALGESIA; MALE; METHYLENE BLUE; MICE; NG-NITROARGININE METHYL ESTER; PAIN THRESHOLD; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RATS; RATS, WISTAR;

EID: 5644304230     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080104     Document Type: Article

References (30)

1. John MW: Review of symptomatic treatment of diabetes neuropathy. Pharmacotherapy 1994;14:689-697.
2. Brown MJ, Asbury AK: Diabetic neuropathy. Ann Neurol 1984;15:2-12.
3. Clark CM Jr, Lee DA: Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995;332:1210-1217.
4. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF: Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 1988;319:542-548.
5. Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G: C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia 2001;44:889-897.
6. Kim H, Sasaki T, Maeda K, Koya D, Kashiwagi A, Yasuda H: Protein kinase C β-selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons. Diabetes 2003;52:2102-2109.
7. Sasaki T, Yasuda H, Maeda K, Kikkawa R: Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreport 1998;7:243-247.
8. Rodella L, Rezzani R, Corsetti G, Bianchi R: Nitric oxide involvement in the trigeminal hyperalgesia in diabetic rats. Brain Res 2000;865:112-115.
9. Pitei DL, Watkins PJ, Edmonds ME: NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabet Med 1997;14:284-290.
10. Waxman SG, Dib-Hajj S, Cummins TR, Black JA: Sodium channels and pain. Proc Natl Acad Sci USA 1999;96:7635-7639.
11. Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil, a phosphodiesterase inhibitor, enhances antinociceptive effect of morphine. Pharmacology 2003;67:150-156.
12. Inoue T, Mashimo T, Shibata M, Shibuta S, Yoshiya I: Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model. Brain Res 1998;792:263-270.
13. Torres-Lopez JE, Arguelles CF, Granados-Soto V: Participation of peripheral and spinal phosphodiesterases 4 and 5 in inflammatory pain. Proc West Pharmacol Soc 2002;45:141-143.
14. Beavo JA: Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 1995;75:725-748.
15. Pyne NJ, Arshavsky V, Lochhead A: cGMP signal termination. Biochem Soc Trans 1996;24:1019-1022.
16. Kitto KF, Haley JE, Wilcox GL: Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett 1992;148:1-5.
17. Inoue T, Mashimo T, Shibuta S, Yoshiya I: Intrathecal administration of a new nitric oxide donor, NOC-18, produces acute thermal hyperalgesia in the rat. J Neurol Sci 1997;153:1-7.
18. Tegeder I, Schmidtko A, Niederberger E, Ruth P, Geisslinger G: Dual effects of spinally delivered 8-bromo-cyclic guanosine monophosphate (8-bromo-cGMP) in formalin-induced nociception in rats. Neurosci Lett 2002;332:146-150.
19. Chu PC, Lin MT, Shian LR, Leu SY: Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats. Diabetes 1986;35:481-485
20. Courteix C, Bourget P, Caussade F, Bardin M, Coudore F, Fialip J, Eschalier A: Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics? J Pharmacol Exp Ther 1998;285:63-70.
21. Zurek JR, Nadeson R, Goodchild CS: Spinal and supraspinal components of opioid antinociception in streptozocin-induced diabetic neuropathy in rats. Pain 2001;90:57-63.
22. Ahlgren SC, White DM, Levine JD: Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat. J Neurophysiol 1992;68:2077-2085.
23. Kostyuk E, Voitenko N, Kruglikov I, Shmigol A, Shishkin V, Efimov A, Kostyuk P: Diabetes-induced changes in calcium homeostasis and the effects of calcium channel blockers in rat and mice nociceptive neurons. Diabetologia 2001;44:1302-1309.
24. Reagan LP, McEwen BS: Diabetes, but not stress, reduces neuronal nitric oxide synthase expression in rat hippocampus: Implications for hippocampal synaptic plasticity. Neuroreport 2002;13:1801-1804.
25. Watkins CC, Sawa A, Jaffrey S, Blackshaw S, Barrow RK, Snyder SH, Ferris CD: Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000;106:373-384.
26. Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y: Antinociceptive effect of L-arginine in diabetic mice. Eur J Pharmacol 1994;254:113-117.
27. Igwe OJ, Chronwall BM: Hyperalgesia induced by peripheral inflammation is mediated by protein kinase C II isozyme in the rat spinal cord. Neuroscience 2001;104:875-890.
28. Jain NK, Patil CS, Kulkarni SK, Singh A: Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001;909:170-178.
29. FDA: Viagra® tablets (sildenfail citrate): Review and evaluation of pharmacology and toxicology data. Report from the Division of Cardio-renal drug products (HFD-10). Centre for Drug Evaluation and Research. Washington, FDA, pp 121-122.
30. Yuen KC, Baker NR, Rayman G: Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: A double-blind placebo-controlled crossover study. Diabetes Care 2002;25:1699-1703.